rs773010364
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The NM_021619.3(PRDM12):c.995C>A(p.Ala332Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00163 in 1,224,332 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_021619.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRDM12 | NM_021619.3 | c.995C>A | p.Ala332Glu | missense_variant | 5/5 | ENST00000253008.3 | NP_067632.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRDM12 | ENST00000253008.3 | c.995C>A | p.Ala332Glu | missense_variant | 5/5 | 1 | NM_021619.3 | ENSP00000253008.2 | ||
PRDM12 | ENST00000676323.1 | c.906+89C>A | intron_variant | ENSP00000502471.1 |
Frequencies
GnomAD3 genomes AF: 0.00128 AC: 189AN: 147910Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00351 AC: 2AN: 570Hom.: 0 AF XY: 0.00524 AC XY: 2AN XY: 382
GnomAD4 exome AF: 0.00168 AC: 1803AN: 1076318Hom.: 1 Cov.: 31 AF XY: 0.00166 AC XY: 847AN XY: 508926
GnomAD4 genome AF: 0.00128 AC: 189AN: 148014Hom.: 0 Cov.: 32 AF XY: 0.00108 AC XY: 78AN XY: 72174
ClinVar
Submissions by phenotype
Congenital insensitivity to pain-hypohidrosis syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 02, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 28, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at